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INTRODUCTION
Burning mouth syndrome (BMS) is characterized by a
continuous sensation of burning or heat in the oral cavity,
mainly on the tongue, palate and/or gingiva 1-3, in the
absence of a primary cause 4-5. Systemic diseases, such as
diabetes mellitus or anemia, must be ruled out 3. It is most
common among postmenopausal women and causes
intense discomfort and suffering.
There is no defined etiology for BMS other than
precipitating causative factors, and it is still considered
idiopathic. One of the most widely accepted theories is that
the partial or total loss of chorda tympani (facial) nerve
function disinhibits the trigeminal nerve, resulting in pain
along trigeminal pathways, as both taste and pain systems
are regulated by interneurons of the central nervous system
(CNS) 6-8. This theory is based on evidence of neuropathic
mechanisms 9-10, including the loss of small fibers in oral
tissues 11, salivary and somatosensory abnormalities 8-10,12-14,
reduced corneal reflexes 15, and peripheral nerve
degeneration 11-16. Despite the known interaction between
smell and taste 17, we found no studies that investigated it in
relation to BMS.
Thus, the objective of this preliminary study was to
determine tactile, pain, thermal, gustative and olfactory
thresholds in a group of patients with BMS as compared
with controls.
METHODS
This research was approved by the Ethics Committee of
Hospital das Clinicas, Medical School, University of Sao
Paulo (HC-FMUSP), and all patients provided informed
consent. Twenty consecutive patients with BMS, diagnosed
according to the International Association for the Study of
Pain (IASP) criteria 18, were evaluated by the HC-FMUSP
orofacial pain team between August 2007 and January 2008
and then compared with 30 normal subjects. All patients
had BMS for more than 3 years and had no oral infections or
other lesions and no diseases included in the exclusion
criteria.
Inclusion criteria: The study included 20 patients newly
diagnosed with BMS who had not begun pharmacological
treatment and 30 healthy controls with no complaint of
facial or intraoral pain within the last 6 months who were
consecutively selected from patients receiving dental treat-
ment at the Dentistry Division of the hospital.
Exclusion criteria (for patients and controls): Exclusion
criteria included Sjo¨gren syndrome, rheumatological dis-
eases (i.e., fibromyalgia and rheumatoid arthritis), diabetes,
anemia, hyper- or hypothyroidism, generalized pain, and
history of surgery in the facial/oral region. The patients and
controls underwent a systematized evaluation by the
hospital’s general physician to investigate the presence of
systemic diseases. In addition to the clinical exam, a
hematological evaluation of thyroid hormones, glycemia,
rheumatoid factors, including reactive C protein and
hemosedimentation velocity, and hemogram values was
performed.
All subjects underwent a standardized superficial facial
sensibility protocol applied to distinct areas of the face
(bilateral trigeminal branches) and oral mucosa (superior
and inferior arches) 19 in the following order.
(1) Thermal sensibility (using an electrical device designed
at the Functional Neurosurgery Division of HC-FMUSP)
at a temperature range between 0 C˚ and 50 C˚.
(2) Mechanical/tactile sensibility (using microfilaments
from von Frey) ranging from 0.1 g/mm2 to 10.0 g/mm2.
(3) Pain sensibility/superficial algometry (using
MicromarH, Diadema, Sa˜o Paulo, Brazil).
Each thermal and mechanical stimulus was applied three
times, and the threshold was established when the subject
recognized at least two of the three applications. If this did
not happen, the next stimulus in crescent order would be
applied to avoid a tolerance effect. Algometry was
performed with a superficial device and a disposable
0.7615-mm needle. The ophthalmic branch (V1) was
evaluated 1 cm above the eyebrow, and the maxillary
branch (V2) was evaluated 1 cm to the side of the nose wing.
Finally, the mandibular branch (V3) was evaluated 1 cm
below the angle of the lips.
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(4) Gustative thresholds were set according to the following
molar concentrations 20-22.
Sweet (glucose): 0.01; 0.032; 0.1; 0.32; 1.0.
Sour (citric acid): 0.01; 0.032; 0.1; 0.32; 1.0.
Salty (sodium chlorate): 0.01; 0.032; 0.1; 0.32; 1.0.
Bitter (urea): 0.01; 0.032; 0.1; 0.32; 1.0.
A single drop of each concentration was applied and
swallowed by the patient; the results were compared to
results from a single drop of distilled water. When the
stimulus was not perceived, the next concentration was
applied. The patient’s mouth was washed with distilled
water between different tastes.
(5) Olfactory threshold with isopropanol solutions (9.9; 15;
23.3; 32; 48; 53; 70%) 23-24. Each concentration was
offered to the patient along with a bottle of water, and
the patient was asked to choose the bottle containing the
substance three times. The threshold was established
when the patient correctly chose all three times. If the
patient chose incorrectly, the next concentration was
offered along with a bottle of water.
All subjects were evaluated in the sitting position, with
the head resting on a flat surface and the Frankfurt line
parallel to the ground. All evaluations took place at the
same time of day (between 1 and 4 pm) in a silent room with
acoustic protection on the walls and with the door closed.
Only the patient and the researcher were in the room during
evaluations. All patients were evaluated by the same
researcher. The subjects received the same instructions after
being positioned, which were to keep their eyes closed
during the exam and to identify and report whether they felt
the stimuli being applied to the face (by saying ‘‘yes’’ or
‘‘no’’) and what they felt (by naming the stimulus). Only the
researcher knew the order in which the stimuli would be
presented. Finally, all findings were tabulated and statisti-
cally analyzed.
Statistical analysis
For age and algometry, we used the one-factor ANOVA
and Tukey’s test. The Kruskall-Wallis test was used to
analyze facial and oral sensitivity. Finally, gustative and
olfactory thresholds were evaluated with the Kruskall-
Wallis test followed by Dunns test. The level of significance
was p,0.05.
RESULTS
Demographic characteristics
The mean age of subjects was 60.95, and there were 16
women and 4 men in the BMS group. There was a
significant age difference between groups (Table 1).
Somatosensory findings
There were no between-group differences in the somato-
sensory results for the ophthalmic branch, and similar cold
thresholds were noted between the groups. The BMS
patients had higher tactile thresholds at the maxillary
branch (p = 0.001) and higher warm thresholds at the
maxillary (p = 0.032) and mandibular (p = 0.001) branches
(Table 2). The BMS patients had higher pain thresholds at
the ophthalmic and maxillary branches (p,0.05) (Table 3).
There were no intraoral sensibility differences between the
studied groups (p = 0.87).
Gustative evaluation
The gustative evaluation showed significant differences in
all basic tastes (sweet p,0.001; salty p = 0.004; sour p = 0.001;
bitter p= 0.001). The BMS patients had higher salty, sweet
and bitter thresholds but lower sour thresholds (Figure 1).
Neither group exhibited difficulties with taste identification.
Olfactory evaluation
The BMS patients had higher olfactory thresholds
(Figure 2).
DISCUSSION
This study presents evidence that supports the theory that
the neuropathic mechanisms underlying BMS involve the
somatosensory, gustative and olfactory pathways. To our
Table 1 - Age and gender of BMS patients and controls
(N=50).
Groups
Age (¡ standard
deviation) P = 0.0033 Gender (female)
BMS 60.95 (¡12.21) 16 (80.0%)
CG 68.86 (¡9.79) 10 (33.3%)
BMS: Burning mouth syndrome; CG: Control group.
Table 2 - Between-group comparison of superficial sensibility in all modalities (cold, warm, and tactile) given the three
trigeminal branches. Thresholds for the warm (V2 and V3) and tactile (V2) modalities were higher (N=50).
Modalities
V1 V2 V3
BMS CG p BMS CG p BMS CG p
Cold 1.35¡0.67 1.27¡0.45 0.467 1.35¡0.67 1.10¡0.31 0.793 1.40¡0.68 1.27¡0.45 0.076
Warm 1.45¡1.76 1.00¡0.01 0.097 1.40¡0.75 1.01¡0.01 0.032* 1.45¡0.78 1.00¡0.01 0.001*
Tactile 1.40¡0.50 1.03¡0.18 0.064 2.40¡0.50 1.03¡0.18 0.001* 1.40¡0.50 1.03¡0.18 0.095
*Kruskall-Wallis test
V1: Ophthalmic branch; V2: Maxillary branch; V3: Mandibular branch; BMS: Burning mouth syndrome; CG: Control group.
Table 3 - Between-group comparison of the superficial
algometry means for all trigeminal branches. Thresholds
at V1 and V2 (N=50) were higher.
V1 (p=0.289) V2 (p = 0.132) V3 (p= 0.143)
BMS 31.900¡20.83* 28.067¡9.36* 25.067¡8.93
CG 24.733¡9.73 23.000¡12.50 22.350¡7.88
*One-factor ANOVA and Tukey’s test (p,0.05)
V1: Ophthalmic branch; V2: Maxillary branch; V3: Mandibular branch;
BMS: Burning mouth syndrome; CG: control group.
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knowledge, this is the first time the olfactory threshold of
BMS patients has been investigated, and the findings show
abnormalities in the trigeminal, gustatory and olfactory
systems. Thus, these findings support the notion that central
sensitization is involved in the physiopathology of this
disease 6-8. The pathophysiology is complex because of the
Figure 1 - Compared to controls, the BMS patients had higher thresholds for sweet, salty and bitter tastes, but they had lower sour taste
thresholds (N=50).
Figure 2 - The BMS patients had higher olfactory thresholds than the controls (N=5).
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overlapping of cortical areas that receive afferents with
trigeminal and gustative inputs 25. Furthermore, taste
perception includes olfaction, and olfaction also requires
somatosensory input 26. These three sensory systems (i.e.,
trigeminal, gustatory and olfactory) show abnormal inter-
actions in patients with BMS.
Our results are similar to those of previous studies that
show decreased somatosensory perception in BMS patients,
including higher tactile and thermal thresholds in all
trigeminal branches 8,9,12, higher taste thresholds 10,13,14
and a delay in the blink reflex 15. Thermal abnormalities in
the orofacial region that only pertain to the perception of
warmth might be associated with the burning sensation
these patients describe, and it has been reported that
abnormal functioning of the warmth-perceiving pathways
can induce burning pain sensations 27. It is possible that in
BMS, there is a malfunction in warmth detection that leads
to a pain sensation and, when it becomes chronic, induces
other somatosensory, gustative and olfactory disturbances
through central mechanisms, including neuroplasticity at
the cortical areas responsible for sensory interaction 26.
Abnormal taste has been described as a consequence of the
loss of warmth detection 27. In this sense, BMS could be
described as a phantom sensation of heat on the tongue.
In the gustative evaluation, the sweet, salty and bitter
tastes had higher thresholds, but the sour taste had lower
thresholds. Sour is the taste that involves the activity of H+
ions directly through channels in the receptor membranes,
which also can activate small pain fibers. In addition to
peripheral nerve degeneration 11,16, a more sensitive
perception of acids (for taste and pain) could be a peripheral
mechanism of BMS.
A limitation in this study is the small sample size. Larger
studies are necessary to confirm the reported results.
Although there was an age difference between the groups,
the implications of this difference are controversial, espe-
cially for gustation and olfaction, which apparently does not
differ by age or gender 28.
In conclusion, this preliminary study shows evidence of
abnormal thresholds for pain, tactile, warmth perception,
olfaction and gustation. Given these results and previous
results in the literature, we propose a phantom heat
sensation involving central pathophysiology as a mechan-
ism in BMS.
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